An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil.

<h4>Background</h4>Treatment of cutaneous leishmaniasis (CL) remains challenging since the drugs currently used are quite toxic, thus contributing to lethality unrelated to the disease itself but to adverse events (AE). The main objective was to evaluate different treatment regimens with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carla Oliveira-Ribeiro, Maria Inês Fernandes Pimentel, Liliane de Fátima Antonio Oliveira, Érica de Camargo Ferreira E Vasconcellos, Fatima Conceição-Silva, Armando de Oliveira Schubach, Aline Fagundes, Cintia Xavier de Mello, Eliame Mouta-Confort, Luciana de Freitas Campos Miranda, Claudia Maria Valete-Rosalino, Ana Cristina da Costa Martins, Raquel de Vasconcellos Carvalhaes de Oliveira, Leonardo Pereira Quintella, Marcelo Rosandiski Lyra
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/9b4a641b8bb2434f993f136602e5c7ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!